The optimal endovascular treatment method of ruptured basilar artery dissection still remains controversial. We reported a case with ruptured basilar artery dissection involving the left anterior inferior cerebellar artery. The dissecting aneurysm was successfully treated with two overlapping Low-profile Visualized Intraluminal Support stents and the preservation of antegrade blood flow of the anterior inferior cerebellar artery was achieved. Three-month and six-month follow-ups revealed good clinical and angiographic results, although controversies regarding long-term stability remained to be addressed.
Introduction
Basilar artery dissection (BAD) is a disease with heterogeneous clinical presentation and prognosis, thus, case management is challenging and has to be tailored to each patient. 1 Acute and chronic dissecting aneurysms of basilar trunk are known to have severe morbidity and 20% to 30% mortality. Treatment of basilar artery aneurysms is difficult because both bleeding and thrombosis can happen in the same patient. 2 Until now, there have been very few reports of treatment for BAD in the literature to elicit any strong evidence. More studies are still required to find effective treatment for this disease. The Low-profile Visualized Intraluminal Support (LVIS) stent has small cell size (<0.9 mm) and high metal coverage rate (23% on average) and was recently developed for endovascular embolization of intracranial aneurysms.
Case illustration
A patient in his fourth decade of age complained of headache, nausea and vomiting. A neurological examination also showed neck rigidity. An unenhanced computed tomography (CT) scan (Figure 1(a) ) revealed subarachnoid hemorrhage in the ambient cistern and pontine cistern. Digital subtraction angiography (DSA) (Figure 1 (b) and (c)) performed on the day after admission illustrated irregular expansion of the basilar artery, indicating a BAD aneurysm. The aneurysm consisted of two blebs. DSA also showed that the left anterior inferior cerebellar artery (AICA) was stemmed from the aneurysmal sac.
The radiological results were then discussed in a multidisciplinary conference including neuroradiological, neurological and neurosurgical colleagues in order to achieve a low-risk and adequate treatment of the BAD aneurysm. The agreed treatment was to cover the whole aneurysm with two overlapping LVIS stents.
This individual was preloaded with aspirin 300 mg and clopidogrel 300 mg 2 h before the procedure. Under general anesthesia and systemic heparinization, a 6F Chaperon guiding catheter was navigated into the left vertebral artery at C2 level. Headway-21 microcatheter assisted by Traxcess 14 microwire was thereafter advanced Dual antiplatelet treatment (aspirin 100 mg daily and clopidogrel 75 mg daily) was administered for six weeks after the procedure. Clopidogrel was then discontinued while aspirin was maintained.
Clinical follow-up at three months, six months and one year revealed a good clinical result without any neurological deficits. DSA follow-up at three months (Figure 1(h) ) showed decreased filling of the aneurysm compared with immediate outcome and stable morphology of the left AICA. The dissecting aneurysm completely disappeared on six-month follow-up DSA (Figure 1(i) ) and no in-stent-stenosis was noted. However, mild stenosis of the opening of the left AICA was noted.
Discussion
BADs are rare and have a high rebleeding rate in the acute phase, estimated to be between 43% and 86% in untreated dissecting aneurysms. 3 Surgical options for treatment of such cases including clipping, proximal ligation, wrapping and trapping were difficult because of the deep location and because perforators were involved that should be preserved. Endovascular treatments of BAD remain an ongoing challenge, especially when perforating arteries or essential branches are involved.
Endovascular treatments include coils, conventional stents with or without coils, and flow diverters. Coils should be considered in large pseudoaneurysms. BADs provide no real walls for coils thus intra-operative rupture and re-rupture might have a patent incidence. The application of a flow diverter is interesting but still should be carefully considered. A flow diverter provides smaller pores and higher metal coverage rate (MCR); however, it may also significantly reduce blood flow into the perforators. The risk of thromboembolic complications is another shortcoming that needs to be weighed. Stent-in-stent technique is an alternative strategy, which provides similar MCR and preservation of perforator flow when a flow diverter is not available or not suitable. 4 Furthermore, more than two stents could be used in the stent-in-stent technique, such as three overlapping stents. 5 In this case, the left AICA was stemmed from the dissecting aneurysm, thus coiling was not suggested because of high risk of procedural hemorrhage and occlusion of the AICA. There was no strong evidence of application of flow diverter in BAD. Finally, two overlapping LVIS stents were deployed to achieve a good occlusion result of the dissecting aneurysm and preservation of the AICA.
Jiang et al. reported 28 BAD patients treated with various endovascular regimens including stent-only, coils-only and stent-assisted embolization, which were then proved safe and effective. Stent placement and initial complete occlusion were considered favorable factors for stable or improved outcome at followup. 6, 7 A flow diverter was another alternative treatment and has been reported in some studies. However, treatment of BAD with flow diverters still remained controversial because of the high complication rate. Gong et al. successful treated a growing BAD aneurysm with a pipeline flow diverter embolization device, resulting in complete obliteration of the aneurysm and good clinical recovery. 8 Two problems should be addressed before treatment of basilar trunk artery dissecting aneurysms. First, the metal coverage of the planned stent should be assessed. LVIS possesses higher metal coverage (23% on average), compared with 11% for Neuroform, 10% for Enterprise and 6% for Solitaire stents. Thus, it provides better flow diversion effects and hemodynamic changes after stenting and improves long term outcomes. The cell size (<0.9 mm) could be manually altered to achieve even higher metal coverage. 9 However, stent placement may induce intimal hyperplasia and, especially in small branches, this could lead to stenosis or even occlusion of branches. In this case, mild stenosis of the left AICA at follow-up might be caused by small cell size formed by the overlapping stents. Whether stenosis of the left AICA continues to develop should be investigated in further follow-ups. Second, long-term efficacy of the treatment has yet to be confirmed. Liu et al. reported a basilar artery dissecting aneurysm treated with a LEO stent. The basilar artery was completely occluded at six-month follow-up and the aneurysm disappeared even though the patient remained neurologically normal. 10 Similar metal coverage to a flow diverter was achieved in our report with two overlapping stents and the blood flow of the AICA was well preserved. Thus, treatment of BAD aneurysms with flow diverter or stent-in-stent technique should be addressed with careful patient selection and aneurysm assessment.
Conclusion
This case illustrated that stent-in-stent technique could be an alternative technique of flow diversion in treating BADs. However, high metal coverage rate and high incidence of thromboembolic events, especially in perforators, are worth highlighting.
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